Ezetimibe/Simvastatin 10/10 Tablets
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
NBK Pharmaceuticals Co., Ltd.
MFDS item code 201906494 · Approved 2019.09.17
This product's status changed to Approval withdrawn on 2023.10.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
This medicine helps to lower total cholesterol, LDL-cholesterol, apoB, and triglycerides and increase HDL-cholesterol in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial, as well as in those with mixed hyperlipidemia. It can also be used as an adjunct to other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia or alone when other treatments are ineffective. This treatment should be combined with an appropriate diet and should be used when non-drug measures are not adequately effective. For patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia, a treatment plan considering various risk factors will be developed. Prior to administering this medicine, it is important to identify and treat secondary causes of dyslipidemia, such as diabetes and hypothyroidism. This medicine is used to reduce risks related to hypercholesterolemia and atherosclerotic vascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 4. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see 4. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 5. Interactions under Precautions for Use.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.
This medicine may pose a risk of myopathy or rhabdomyolysis. This risk may be higher when taking higher doses of this medicine or in combination with other medications. It should not be administered to patients with any allergy to its components or severely impaired liver function, or to pregnant or breastfeeding women. During use, if symptoms such as muscle pain, muscle weakness, or unexplained muscle discomfort occur, medical personnel should be notified immediately. Additionally, this medicine may affect liver function; hence, patients with liver disease or elevated liver function test results should consult a physician before use. This medicine can interact with several other drugs; especially when taken with drugs that interfere with hepatic drug metabolism, the risk of muscle-related side effects may increase, so it is important to inform of any other medications being taken. Pregnant women or those who may become pregnant should not take this medicine, and if pregnancy is confirmed, use should be discontinued immediately. Nursing women should also not take this medicine and should discontinue breastfeeding if necessary. The safety and efficacy of this medicine have not been sufficiently proven in children and adolescents, hence caution is required during use. Elderly patients may respond differently to the medication, so caution is required during use. Regular blood tests to monitor liver function and muscle enzyme levels are recommended during use. There is no specific antidote for overdose, so it is crucial to avoid overdosing and consult medical staff immediately if problems arise.
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, avoid storing in excessively hot or cold places, and it is recommended to store it at room temperature between 1 degree and 30 degrees Celsius.
White to pale yellow, biconvex, rectangular tablets
30 tablets/PTP [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
NBK Pharmaceuticals Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.